The Indonesian healthcare startup recently got a US$9 million Series B funding for expansion.
By J Yin
Alodokter wants to be more than just Indonesia’s leading healthcare information website. With the US$9 million investment that it clinched earlier this month, it can ramp up to its goal of becoming Indonesians’ one-stop healthcare app.
Founded in 2014 by its CEO Nathanael Faibis, Alodokter publishes information about common ailments, diseases, drugs and general well-being in Bahasa Indonesia. Registered users can ask questions on its website or via its AI-supported chat app, which are then answered by Alodokter’s team of doctors.
The startup wants to develop its app into a one-stop personalised health manager, through which users can chat with doctors, book offline medical services, manage their medical records and keep track on their lifestyle – all in real-time.
Business research and consulting group Frost & Sullivan forecasts that healthcare spending (public and private) in Indonesia will reach US$60.6 billion in 2018, more than double from 2017. Factors driving such spending are a growing middle class and their demand for quality healthcare services, as well as an increase in lifestyle-related diseases such as diabetes, heart disease and cancer.
Faibis stressed that Alodokter does not want to undermine the doctor’s role: “We are not trying to replace a consultation with a doctor. No health information can do that.”
“Our objective is to give our users the right information they need to take the right decision for their health,” he has also said.